Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
Individualised cellular models of disease are a key tool for precision medicine to recapitulate chronic inflammatory processes. Organoid models can be derived from induced pluripotent stem cells (iPSCs) or from primary stem cells ex vivo. These models have been emerging over the past decade and have...
Main Authors: | Florian Tran, Christine Klein, Alexander Arlt, Simon Imm, Evelyn Knappe, Alison Simmons, Philip Rosenstiel, Philip Seibler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.573562/full |
Similar Items
-
Eradicating infectious disease: can we and should we?
by: Clark Donald Russell
Published: (2011-10-01) -
As Yet Uncultured, or Poorly Culturable Microbes as Sources of Bioactive Agents
by: David John Newman
Published: (2016-11-01) -
Bioengineered Co-culture of organoids to recapitulate host-microbe interactions
by: Min Beom Kim, et al.
Published: (2022-12-01) -
Porcine Intestinal Organoids: Overview of the State of the Art
by: Panpan Ma, et al.
Published: (2022-05-01) -
Will Organoids Fill the Gap towards Functional Precision Medicine?
by: Federica Papaccio, et al.
Published: (2022-11-01)